Literature DB >> 352338

Isolation and some properties of nontoxigenic derivatives of a strain of Clostridium tetani.

T Hara, M Matsuda, M Yoneda.   

Abstract

Nontoxigenic derivatives of a toxigenic strain of Clostridium tetani were isolated gy treatment with acridine orange, N-methyl-N'-nitro-soguanidine, rifampicin or ultraviolet light. The frequency of appearance fo non-toxigenic derivatives on these treatments was 0.8 to 3.2 per cent. The nontoxigenic derivatives peoduced all the same extracellular antigenic and protein components as the toxigenic parent strain, except the toxin and materials cross-reacting with the toxin. The nontoxigenic strains, like the toxigenic parent strain, were lyzed by trratment with mitomycin C. Bacteriophage was detected in the lysates of all the nontoxigenic derivatives produced with mitomycin C, and this bacteriophage was morphologically indistinguishable from that obtained from the toxigenic parent strain. The genetic factor controlling tetanus toxin production is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 352338

Source DB:  PubMed          Journal:  Biken J        ISSN: 0006-2324


  5 in total

1.  Molecular characterization of Clostridium tetani strains by pulsed-field gel electrophoresis and colony PCR.

Authors:  Lucile Plourde-Owobi; Delphine Seguin; Marie-Anne Baudin; Catherine Moste; Bachra Rokbi
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 2.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

Review 4.  Tetanus toxin.

Authors:  B Bizzini
Journal:  Microbiol Rev       Date:  1979-06

5.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.